Abstract:Background: Laparoscopic sleeve gastrectomy (LSG) is a sustainable technique that effectively treats morbid obesity. However, the molecular mechanisms underlying the improvement of metabolic health following this process warrants more investigation. This study investigates LSG-related molecules and uses bulk RNA-sequencing high-throughput analysis to unravel their regulatory mechanisms. Methods: Peripheral blood mononuclear cells (PBMC) were collected from ten obese patients with BMI ≥ 32.5 kg/m 2 in the Department of General Surgery of Kunming First People's Hospital. After LSG, patients were followed up for one month, and blood samples were retaken. Blood samples from ten patients before and after LSG and bulk RNA-Seq data were analyzed in this study. LSG-associated gene expression was detected by weighted gene coexpression network analysis (WGCNA) and differential analysis. Subsequently, essential signature genes were identified using logistic least absolute shrinkage and selection operator (LASSO) and support vector machine-recursive feature elimination (SVM-RFE) algorithms. Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and single-sample gene set enrichment analysis (ssGSEA) were utilized to reveal the potential functions of the target genes. Furthermore, the Pearson correlation of signature genes with leptin and lipocalin was also explored. Finally, we constructed a robust endogenous RNA (ceRNA) network based on miRWalk and starBase databases. Results: We identified 18 overlapping genes from 91 hub genes, and 165 differentially expressed mRNAs (DE-mRNA), which were revealed to be significantly associated with immune cells, immune response, inflammatory response, lipid storage, and localization upon functional enrichment analysis. Three signature genes, IRF1 , NFKBIA , and YRDC , were identified from the 18 overlapping genes by LASSO and SVM-REF algorithms. The logistic regression model based on the three signature genes highlighted how robustly they discriminated between samples. ssGSEA indicated these genes to be involved in lipid metabolism and degradation pathways. Moreover, leptin levels were significantly reduced in patients undergoing LSG, and NFKBIA significantly negatively correlated with leptin. Finally, we identified how the long non-coding RNA (lncRNA) ATP2B1-AS1 regulated the expression of the signature genes by competitively binding to six microRNAs (miRNAs), which were hsa-miR-6509-5p, hsa-miR-330-5P, hsa-miR-154-5P, hsa-miR-145-5P, hsa-miR4726-5P and hsa-miR-134-5P. Conclusion: This study identified three critical regulatory genes significantly differentiated between patients before and after LSG treatment and highlighted their potentially crucial role after bariatric surgery. This provides novel insights to increase our understanding of the underlying mechanisms of weight loss and associated metabolic improvement after bariatric surgery.

Changes in Serum Nesfatin-1 after Laparoscopic Sleeve Gastrectomy Are Associated with Improvements in Nonalcoholic Fatty Liver Disease.

Gut microbiome and microbial metabolites in NAFLD and after bariatric surgery: Correlation and causality

220-LB: Serum Lipocalin-2 (LCN2): Potential Indices Associated with Weight Loss and Metabolic Improvement after Laparoscopic Sleeve Gastrectomy (LSG)

The changes of serum fibrinogen-like protein 1 levels associated with improved liver function and uric acid after laparoscopic sleeve gastrectomy

Correlation Between Sex Hormones and Non-alcoholic Fatty Liver Disease Before and After Laparoscopic Sleeve Gastrectomy

Serum Fibrinogen-Like Protein 1 Levels in Obese Patients Before and after Laparoscopic Sleeve Gastrectomy: A Six-Month Longitudinal Study.

Effect of metabolic surgery in treatment of severe obesity with nonalcoholic fatty liver disease

The Relationship Between Lipocalin-2 Level and Hepatic Steatosis in Obese Patients with NAFLD after Bariatric Surgery.

Abdominal Magnetic Resonance Imaging Assessment and Quantification of Pancreatic and Liver Adipose Tissues in Obesity Before and after Laparoscopic Sleeve Gastrectomy

Longitudinal changes of serum metabolomic profile after laparoscopic sleeve gastrectomy in obesity

Serial changes in metabolic dysfunction-associated steatotic liver disease after sleeve gastrectomy and their associations with abdominal adiposity: A prospective cohort study

Effects of laparoscopic sleeve gastrectomy on nonalcoholic fatty liver disease and TGF-β signaling pathway

Increased plasma genistein after bariatric surgery could promote remission of NAFLD in patients with obesity

Alterations in Fat Mass and Bone Mineral Density Are Associated with Decreased Lipocalin-2 After Laparoscopic Sleeve Gastrectomy in Obese Chinese Women

Therapeutic Effects of Metabolic Bariatric Surgery on Non-Alcoholic Fatty Liver Disease Are Influenced by Low Density Lipoprotein

Relationship Between Weight Loss, Changes in Serum hs-CRP Levels and apo A-1 Lipoprotein, and High-Density Lipoprotein-Cholesterol Ratios as Predictors for Improved Cardiovascular Risk Factors After Laparoscopic Sleeve Gastrectomy

Lower Baseline Serum Triglyceride Levels Are Associated with Higher Decrease in Body Mass Index after Laparoscopy Sleeve Gastrectomy among Obese Patients

Investigating the change in gene expression profile of blood mononuclear cells post-laparoscopic sleeve gastrectomy in Chinese obese patients

Serum FABP1 Levels Correlate Positively with Obesity in Chinese Patients after Laparoscopic Sleeve Gastrectomy: a 12-Month Follow-up Study.

Changes in Sex Hormones After Laparoscopic Sleeve Gastrectomy in Chinese Obese Men: a 12-Month Follow-Up

Anaemia and Related Nutritional Deficiencies in Chinese Patients with Obesity, 12 Months Following Laparoscopic Sleeve Gastrectomy.